GGrantIndex
← Leaderboards

Heidi R Flori

University Of Michigan At Ann Arbor

$3,688,598
Attributed
$6,613,147
Total exposure
10
Grants
1
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $958.6K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$6,613,147 · 10

By mechanism

R01$5,389,620 · 3
K23$600,533 · 1
R21$459,479 · 1
M01$163,515 · 5

Top collaborators

Most similar at University Of Michigan At Ann Arbor

Same institution · by research overlap

Others in their field

Top investigators on “Lung Injury

Research focus

Lung InjuryHuman SubjectClinical ResearchFutureChildMechanical VentilationFunctional DisorderPlasmaMorbidity - Disease RateAdultPrognosisAdult Respiratory Distress SyndromeSepsisSubgroupChildhoodBiomarkerIntensive CarePediatricsGenesResponseEnrollmentHigh RiskAncillary StudyGenetic Markers

Grant awards (30)

DIscovering SubPhenotypes and ENdotypes in pediatric SEpsis-induced MODS: the DISPENSE Study$697,256
R01 · FY2025 · HD · contact PI
ENdotypes in Children with Severe Acute Respiratory Distress SyNdrome: ImpAct on REsponse to Treatment (ENSNARE)$732,146
R01 · FY2023 · HL
ENdotypes in Children with Severe Acute Respiratory Distress SyNdrome: ImpAct on REsponse to Treatment (ENSNARE)$749,203
R01 · FY2022 · HL
ENdotypes in Children with Severe Acute Respiratory Distress SyNdrome: ImpAct on REsponse to Treatment (ENSNARE)$697,295
R01 · FY2021 · HL
ENdotypes in Children with Severe Acute Respiratory Distress SyNdrome: ImpAct on REsponse to Treatment (ENSNARE)$756,602
R01 · FY2020 · HL
Leveraging Biomarkers to Identify Subphenotypes in Children with Acute Respiratory Distress Syndrome$201,987
R21 · FY2020 · HD
Leveraging Biomarkers to Identify Subphenotypes in Children with Acute Respiratory Distress Syndrome$257,492
R21 · FY2019 · HD
Genetic variation and biomarkers in children with acute lung injury$321,063
R01 · FY2012 · HL
Genetic variation and biomarkers in children with acute lung injury$52,029
R01 · FY2012 · HL
Genetic variation and biomarkers in children with acute lung injury$376,861
R01 · FY2011 · HL
Genetic variation and biomarkers in children with acute lung injury$378,385
R01 · FY2010 · HL
Genetic variation and biomarkers in children with acute lung injury$394,136
R01 · FY2009 · HL
Genetic variation and biomarkers in children with acute lung injury$234,644
R01 · FY2009 · HL
VAP$88,547
M01 · FY2005 · RR
CALIFORNIA UNEXPLAINED PNEUMONIA PROJECT$8,661
M01 · FY2005 · RR
LONG TERM FOLLOW-UP OF PERDIATRIC PATIENTS WITH ACUTE LUNG INJURY$7,340
M01 · FY2005 · RR
ACUTE LUNG INJURY STUDY$917
M01 · FY2005 · RR
MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT AW$120,082
K23 · FY2004 · RR
California Unexplained Pneumonia Project$18,030
M01 · FY2004 · RR
Acute Lung Injury Study$7,934
M01 · FY2004 · RR
Follow-up ALI$6,287
M01 · FY2004 · RR
MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT AW$120,082
K23 · FY2003 · RR
MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT AW$120,082
K23 · FY2002 · RR
PEDIATRIC ACUTE LUNG INJURY--DEMOGRAPHICS, BIOCHEMICAL MEDIATORS &OUTCOME$0
M01 · FY2002 · RR
MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT$120,111
K23 · FY2001 · RR
PEDIATRIC ACUTE LUNG INJURY--DEMOGRAPHICS, BIOCHEMICAL MEDIATORS &OUTCOME$0
M01 · FY2001 · RR
MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT$120,176
K23 · FY2000 · RR
PEDIATRIC ACUTE LUNG INJURY--DEMOGRAPHICS, BIOCHEMICAL MEDIATORS &OUTCOME$25,799
M01 · FY2000 · RR
PEDIATRIC ACUTE LUNG INJURY--DEMOGRAPHICS, BIOCHEMICAL MEDIATORS &OUTCOME$0
M01 · FY2000 · RR
PEDIATRIC ACUTE LUNG INJURY--DEMOGRAPHICS, BIOCHEMICAL MEDIATORS &OUTCOME$0
M01 · FY2000 · RR